| Disease ID | Disease name | Source of annotation with IFNG | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 607948 | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO | OMIM | link to OMIM | 11 | IFNG, TIRAP, CD209, IFNGR1, MC3R, CISH, CCL2, IRGM, SLC11A1, TLR2, SP110 |
| PS191100 | TUBEROUS SCLEROSIS | OMIM | link to OMIM | 4 | TSC2, IFNG, SERPINC1, TSC1 |
| 609423 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO | OMIM | link to OMIM | 16 | HLA-C, IFNG, CCL3, CD209, IL4R, KIR3DL1, CCL2, TLR3, CCR2, CX3CR1, CCL11, CCR5, CXCL12, CCL3L1, CXCR1, IL10 |
| 609135 | APLASTIC ANEMIA | OMIM | link to OMIM | 4 | NBN, PRF1, IFNG, SBDS |
| 609532 | HEPATITIS C VIRUS, SUSCEPTIBILITY TO | OMIM | link to OMIM | 6 | IFNG, PTPRC, IFNL3, KRT8, KRT18, CCR5 |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Salmonella infection | hsa05132 | 6.29 |
| Antigen processing and presentation | hsa04612 | 6.04 |
| Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 |
| Allograft rejection | hsa05330 | 6.91 |
| Graft-versus-host disease | hsa05332 | 6.84 |
| Regulation of autophagy | hsa04140 | 7.48 |
| Osteoclast differentiation | hsa04380 | 5.64 |
| HIF-1 signaling pathway | hsa04066 | 5.9 |
| Type I diabetes mellitus | hsa04940 | 6.79 |
| Cytokine-cytokine receptor interaction | hsa04060 | 4.67 |
| Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
| African trypanosomiasis | hsa05143 | 7.68 |
| Leishmaniasis | hsa05140 | 6.32 |
| Amoebiasis | hsa05146 | 5.82 |
| Epstein-Barr virus infection | hsa05169 | 4.97 |
| Malaria | hsa05144 | 7.15 |
| Toxoplasmosis | hsa05145 | 5.71 |
| Influenza A | hsa05164 | 5.21 |
| Herpes simplex infection | hsa05168 | 5.08 |
| Measles | hsa05162 | 5.6 |
| TGF-beta signaling pathway | hsa04350 | 6.41 |
| Proteasome | hsa03050 | 7.21 |
| Systemic lupus erythematosus | hsa05322 | 5.95 |
| Rheumatoid arthritis | hsa05323 | 6.05 |
| Inflammatory bowel disease (IBD) | hsa05321 | 6.43 |
| T cell receptor signaling pathway | hsa04660 | 6.01 |
| Jak-STAT signaling pathway | hsa04630 | 5.44 |
| Tuberculosis | hsa05152 | 5.17 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| Interferon Signaling | R-HSA-913531 | 4.95 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
| Regulation of IFNG signaling | R-HSA-877312 | 9.18 |
| Interferon gamma signaling | R-HSA-877300 | 5.67 |
| Immune System | R-HSA-168256 | 2.37 |
| GO term | GO ID | GO IC |
|---|---|---|
| cytokine receptor binding | GO:0005126 | 4.14 |
| cytokine activity | GO:0005125 | 4.34 |
| interferon-gamma receptor binding | GO:0005133 | 9.05 |
| binding | GO:0005488 | 0.18 |
| protein binding | GO:0005515 | 0.46 |
| receptor binding | GO:0005102 | 2.43 |